Clinical Trial Update: The Effects of Lemborexant on the Ability to Sleep During Daytime [Phase 2]

View source ↗

Summary

This is a Phase 2 trial update examining lemborexant's effect on daytime sleep ability in shift work sleep disorder. The study status is terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Shift Work Sleep Disorder

Drugs mentioned

• Lemorexant (lemborexant)

Snippet

Sponsor: Centre Integre Universitaire de Sante et Services Sociaux du Nord de l'ile de Montreal | Conditions: Shift-Work Sleep Disorder | Phase 2 | Status: TERMINATED